id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-308760-xonuu04p	Clerici, Bianca	A case of newly diagnosed immune thrombocytopenia in the COVID-19 era	2020-11-12		.txt	text/plain	2165	116	47	First-line treatment options for ITP include corticosteroids and intravenous immunoglobulin (IvIg); of the two, corticosteroids induce a more persistent increase in platelet count, and appear more suitable in this case. In this patient, the benefits of a rapid increase in platelet count must be weighed against the risk of deterioration of the ongoing viral infection, of superimposed hospital-acquired infections, of liver impairment, and of venous thromboembolic events, which might be favored by ITP itself [6, 7] , the treatment with a TPO-RA [8] , the suspected presence of a neoplasm, the length of hospitalization and SARS-CoV-2 infection [9, 10] . The impact of the anti-CD20 activity of Rituximab on the course of SARS-CoV-2 infection in a patient on steroid treatment was unknown and particularly worrisome given the crucial role of humoral immunity in infection contrast [11, 12] .	./cache/cord-308760-xonuu04p.txt	./txt/cord-308760-xonuu04p.txt